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Near a bifurcation point, the response time of a system is expected to diverge due to the phe-
nomenon of critical slowing down. We investigate critical slowing down in well-mixed stochastic
models of biochemical feedback by exploiting a mapping to the mean-field Ising universality class.
This mapping allows us to quantify critical slowing down in experiments where we measure the
response of T cells to drugs. Specifically, the addition of a drug is equivalent to a sudden quench
in parameter space, and we find that quenches that take the cell closer to its critical point result
in slower responses. We further demonstrate that our class of biochemical feedback models exhibits
the Kibble-Zurek collapse for continuously driven systems, which predicts the scaling of hysteresis
in cellular responses to more gradual perturbations. We discuss the implications of our results in
terms of the tradeoff between a precise and a fast response.
I. INTRODUCTION
Critical slowing down is the phenomenon in which the
relaxation time of a dynamical system diverges at a bi-
furcation point [1]. Biological systems are inherently dy-
namic, and therefore one generally expects critical slow-
ing down to accompany transitions between their dy-
namic regimes. Indeed, signatures of critical slowing
down, including increased autocorrelation time and in-
creased fluctuations, have been shown to precede an ex-
tinction transition in many biological populations [2, 3],
including bacteria [4], yeast [5], and entire ecosystems
[6]. Similar signatures are also found in other biological
time series, including dynamics of protein activity [7] and
neural spike dynamics [8].
Canonically, critical slowing down depends on scal-
ing exponents that define divergences along particular
parameter directions in the vicinity of a critical point
[9]. Therefore, connecting the theory of critical slowing
down to biological data requires identification of thermo-
dynamic state variables, their scaling exponents, and a
principled definition of distance from the critical point.
However, in most biological systems it is not obvious how
to define the thermodynamic state variables, let alone
scaling exponents and distance from criticality. In a pre-
vious study [10] we showed how near its bifurcation point,
a class of biochemical systems can be mapped to the
mean-field Ising model, thus defining the state variables
and their associated scaling exponents. This provides
a starting point for the investigation of critical slowing
∗These authors contributed equally.
†Electronic address: amugler@purdue.edu
down in such systems, as well as how to apply such a
theory to experimental data.
Additionally, most studies of critical slowing down in
biological systems investigate the response to a sudden
experimental perturbation (a “quench”), such as a dilu-
tion or the addition of a nutrient or drug. This leaves un-
explored the response to gradual environmental changes,
a common natural scenario. When a gradual change
drives a system near its critical point, critical slowing
down delays the system’s response such that no matter
how gradual the change, the response lags behind the
driving. In physical systems this effect is known as the
Kibble-Zurek mechanism [11, 12], which predicts these
nonequilibrium lagging dynamics in terms of the expo-
nents of the critical point. It remains unclear whether
and how the Kibble-Zurek mechanism applies to biolog-
ical systems.
Here we investigate critical slowing down for well-
mixed biochemical networks with positive feedback, and
we use our theory to interpret the response of immune
cells to an inhibitory drug. Using our previously de-
rived mapping [10], we show theoretically that critical
slowing down in our class of models proceeds according
to the static and dynamic exponents of the mean-field
Ising universality class. The mapping identifies an effec-
tive temperature and magnetic field in terms of the bio-
chemical parameters, which defines a distance from the
critical point that can be extracted from experimental
fluorescence data. We find that drug-induced quenches
that take an immune cell closer to its critical point result
in longer response times, in qualitative agreement with
our theory. We then show theoretically that our sys-
tem, when driven across its bifurcation point, falls out
of steady state in the manner predicted by the Kibble-
Zurek mechanism, thereby extending Kibble-Zurek the-
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FIG. 1: (a) Inside a cell, a chemical species X with molecule
number n exists in a bath of other species. (b) We consider
steady-state, quench, and driven dynamics for the bath, and
focus on the autocorrelation time τc, response time τr, and
driving time τd, respectively.
ory to a biologically relevant nonequilibrium setting. Our
work elucidates the effects of critical slowing down in bi-
ological systems with feedback, and provides insights for
interpreting cell responses near a dynamical transition
point.
II. RESULTS
We consider a well-mixed reaction network in a cell
where X is the molecular species of interest, and the
other species A, B, C, etc. form a chemical bath for X
[Fig. 1(a)]. Whereas previously we considered only the
steady state distribution of X [10], here we focus on dy-
namics in and out of steady state. Specifically, as shown
in Fig. 1(b), we consider (i) steady state, where the bath
is constant in time; (ii) a quench, where the bath changes
its parameters suddenly; and (iii) driving, where the bath
changes its parameters slowly and continuously. In each
case we are interested in a corresponding timescale: (i)
the autocorrelation time τc of X, (ii) the response time
τr of X, and (iii) the driving time τd of the bath.
First we review the key features of our stochastic
framework for biochemical feedback and its mapping to
the mean-field Ising model [10]. We consider an arbitrary
number of reactions r in which X is produced from bath
species Y ±r and/or X itself (feedback),
jrX + Y
+
r
⇀↽ (jr + 1)X + Y
−
r , (1)
where jr are stoichiometric integers. The probability of
observing n molecules of species X in steady state ac-
cording to Eq. 1 is
pn =
p0
n!
n∏
j=1
fj , (2)
where p−10 =
∑∞
n=0(1/n!)
∏n
j=1 fj is set by normaliza-
tion, and fn is a nonlinear feedback function governed
by the reaction network. The inverse of Eq. 2,
fn =
npn
pn−1
, (3)
allows calculation of the feedback function from the dis-
tribution. The function fn determines an effective order
parameter, reduced temperature, and magnetic field,
m ≡ n∗ − nc
nc
, h ≡ 2(fnc − nc)−f ′′′ncn3c
, θ ≡ 2(1− f
′
nc)
−f ′′′ncn2c
,
(4)
respectively, where nc is defined by f
′′
nc = 0, and n∗
are the maxima of pn. Qualitatively, nc sets the typi-
cal molecule number, θ drives the system to a unimodal
(θ > 0) or bimodal (θ < 0) state, and h biases the sys-
tem to high (h > 0) or low (h < 0) molecule numbers.
The critical point occurs at θ = h = 0. The state vari-
ables m, θ, and h scale according to the exponents α = 0,
β = 1/2, γ = 1, and δ = 3 of the mean-field Ising univer-
sality class. Detailed analysis of this mapping in steady
state is found in our previous work [10].
Near the critical point, all specific realizations of a class
of systems scale in the same way, and therefore it suffices
to consider a particular realization of Eq. 1 from here
on. We choose Schlo¨gl’s second model [10], a simple and
well-studied case [13–20] in which X is either produced
spontaneously from bath species A, or in a trimolecular
reaction from two existing X molecules and bath species
B,
A
k+1−−⇀↽−
k−1
X, 2X +B
k+2−−⇀↽−
k−2
3X. (5)
In this case the feedback function is
fn =
aK2 + s(n− 1)(n− 2)
(n− 1)(n− 2) +K2 , (6)
where we have introduced the dimensionless quantities
a ≡ k+1 nA/k−1 , s ≡ k+2 nB/k−2 , and K2 ≡ k−1 /k−2 in
terms of the reaction rates and the numbers of A and
B molecules. Given Eqs. 4 and 6, the effective thermo-
dynamic variables nc, θ, and h can be written in terms
of a, s, and K or vice versa [10], with 1/k−1 setting the
units of time.
A. Critical slowing down in steady state
In steady state, critical slowing down causes correla-
tions to become long-lived near a dynamical transition
point. Qualitatively, the fixed point is transitioning from
stable to unstable, and therefore the basin of attraction is
becoming increasingly wide. As a result, a dynamic tra-
jectory takes increasingly long excursions from the mean,
making it heavily autocorrelated. The autocorrelation
time τc diverges at the critical point according to [21]
τc|h=0 ∼ |θ|−νz, (7)
τc|θ=0 ∼ |h|−νz/βδ, (8)
where we expect νz = 1 for mean-field dynamics [9, 22].
Here the autocorrelation time τc is defined as
τc =
1
κ(0)
∫ ∞
0
dt κ(t), (9)
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FIG. 2: Critical slowing down in steady state. (a) Autocor-
relation time τc in Schlo¨gl model (Eq. 9) peaks with field h
when reduced temperature θ = 0. Height increases and loca-
tion moves to h = 0 as molecule number nc increases. Time
is in units of 1/k−1 . (b) At large nc, τc scales with |h| with
expected exponent of νz/βδ = 2/3. Inset: τc at θ = h = 0
scales as n
1/2
c . In a and inset of b, τc is calculated using
eigenfunctions with cutoff N = max(100, 3nc); in main panel
of b, τc is calculated using batch means with 250 trajectories,
duration T = 105, and batch time τb = 2,222 (see Appendix
A).
where κ(t) = 〈n(0)n(t)〉− n¯2 is the steady-state autocor-
relation function, κ(0) = σ2 is the variance, and we have
taken the start time to be t = 0 without loss of generality
because the system is in steady state.
To confirm the value of νz, we plot τc vs. h at θ = 0
(Eq. 8). We calculate τc either directly from the mas-
ter equation or from stochastic simulations [23] using the
method of batch means [24] (see Appendix A). The re-
sults are shown in Fig. 2. We see in Fig. 2(a) that τc
indeed diverges with h, and that the location of the di-
vergence approaches the expected value h = 0 as the
molecule number nc increases. We also see that the
height of the peak increases with nc due to the rounding
of the divergence [25]. The inset of Fig. 2(b) plots this
dependence: we see that τc at the critical point θ = h = 0
scales like n
1/2
c for large nc (the application of this de-
pendence to dynamic driving will be discussed in Sec-
tion II C). Finally, we see in the main panel of Fig.
2(b) that when nc is sufficiently large, τc falls off with
|h| with the expected scaling exponent of νz/βδ = 2/3.
Taken together, these results confirm that the divergence
of the autocorrelation time in the Schlo¨gl model obeys the
static exponents of the mean-field Ising universality class
(βδ = 3/2) and the dynamic expectation for mean-field
systems (νz = 1).
B. Quench response and application to immune
cells
When subjected to a sudden environmental change (a
quench), the system will take some finite amount of time
to respond [Fig. 1(b), middle]. We expect that if a quench
takes the system closer to its critical point, the response
time should be longer due to critical slowing down. To
make this expectation quantitative, we define the re-
sponse time τr in terms of the dynamics of the mean
molecule number n¯ as
τr =
1
∆n¯(0)
∫ tmax
0
dt ∆n¯(t), (10)
where the quench occurs at t = 0, we define ∆n¯(t) =
n¯(t)− n¯(tmax), and we ensure that tmax  τr. We com-
pute n¯(t) from the time-dependent distribution pn(t) us-
ing the stochastic simulations. Examples of pn(t) for a
small and a large quench are shown in Fig. 3(a).
We define the distance from the critical point in terms
of the state variables θ and h. Specifically, τc scales iden-
tically with θβδ as it does with h (Eqs. 7 and 8), which
defines the Euclidean distance dc from the critical point
as
dc =
[
(θβδ)2 + h2
]1/2
. (11)
This measure will be important when comparing with the
experiments because, as opposed to in most condensed
matter experiments, it is difficult in the biological exper-
iments we describe to manipulate only one parameter (θ
or h) independently of the other.
To test whether the response time increases with prox-
imity to the critical point, we must define initial values
θ0 and h0 for the environment before the quench, and
a series of values θ and h for the environment after the
quench that are varying distances from the critical point
θ = h = 0. There are many such choices for these values,
but anticipating the experimental results that we will de-
scribe shortly, we choose the initial point (black square)
and final points (colored circles) shown in Fig. 3(b). Dot-
ted curves of equal dc are also shown, which make clear
that larger quenches (yellow circles) take the system far-
ther from the critical point than smaller quenches (blue
circles). The dependence of τr on dc is shown in Fig. 3(c),
and we see that indeed τr decreases as dc increases, or
equivalently the response time increases with proximity
to the critical point.
We now compare our theory with data from immune
cells. We focus on the abundance in T cells of doubly
phosphorylated ERK (ppERK), a protein that initiates
cell proliferation and is implicated in the self/non-self
decision between mounting an immune response or not
[27, 28]. Specifically, we use flow cytometry to measure
the ppERK distribution at various times after the addi-
tion of a drug that inhibits SRC, a key enzyme in the cas-
cade that leads to ERK phosphorlyation (see Appendix
B for experimental methods). When the dose of the drug
is small, the distribution hardly changes [Fig. 3(d), top];
whereas when the dose is large, the distribution changes
significantly [Fig. 3(d), bottom]. The responses to all
doses are shown in Appendix B.
After the addition of the drug, the cells reach a new
steady-state ppERK distribution [green curves in Fig.
3(d)]. The distribution corresponds to an effective feed-
back function via Eq. 3, from which the effective tem-
perature θ and field h can be calculated via Eq. 4 [10].
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FIG. 3: Quench response in theory (left) and in immune
cell experimental data (right). (a) Stochastic simulations
of Shlo¨gl model show effect of small and large parameter
quenches on distribution. Time is in units of 1/k−1 . (b) Initial
(black square) and quenched (colored circles) parameter val-
ues in θ and h space in model; nc = 500. Dotted lines show
contours of equal dc (Eq. 11), distance from critical point
(θ = h = 0). Response time τr in model (c) decreases with
dc and (g) increases with entropy S. (d) Experimental distri-
butions of T cell ppERK fluorescence intensity measured at
times after addition of SRC inhibitor (see Fig. 6 for all doses).
(e) θ and h extracted from initial distribution (black square)
and final distributions (colored circles) for all [SRCi] doses
(color bar). Experimental response time τr (f) decreases with
dc and (h) increases with S. Error bars: for θ and h, standard
error from Savitzky-Golay [26] filter windows 25 ≤ W ≤ 35
[10]; for dc, propagated in quadrature from e; for τr, standard
deviation of Riemann sums spanning left- to right-endpoint
methods to approximate integral in Eq. 12. In h, fluorescence
of one molecule set to I1 = 10.
The values of θ and h calculated from the experimental
distributions are shown in Fig. 3(e). We see that larger
doses take the cells farther from their initial distribution
(black square), as expected. We also see that larger doses
take the system farther from the critical point θ = h = 0.
The general shape of the θ and h values motivated our
choice of theoretical values in Fig. 3(b).
We define the response time to the drug as in Eq.
10, here in terms of the mean fluorescence intensity of
ppERK,
τr =
1
∆I¯(0)
∫ tmax
0
dt ∆I¯(t), (12)
where ∆I¯(t) = I¯(t) − I¯(tmax) and tmax = 30 min. We
calculate the distance from criticality using Eq. 11 as
before, here using the experimental values of θ and h.
We see in Fig. 3(f) that the response time τr decreases
with the distance from criticality dc, consistent with the
prediction from the theory [Fig. 3(c)]. This suggests that
critical slowing down occurs in the response of the T cells
to the drug.
Although in Fig. 3(f) the response time τr comes di-
rectly from the experimental data, the distance from crit-
icality dc is calculated from the experimental data using
expressions from the theory (Eqs. 3 and 4). This makes
the results in Figs. 3(c) and 3(f) not entirely indepen-
dent. To confirm that the agreement between Figs. 3(c)
and 3(f) is not a result of an implicit co-dependence, we
seek a measure that is related to distance from critical-
ity but that is not dependent on the theory. We choose
the entropy of the distribution S = −∑n pn log pn be-
cause near criticality, the distribution is broad and flat,
and therefore we expect the entropy to be large; whereas
far from criticality, the distribution has either one or two
narrow peaks, and therefore we expect the entropy to be
small [10]. Indeed, we see in Fig. 3(g) that in the theory,
the response time τr increases with the entropy S, con-
sistent with the fact that it decreases with the distance
from criticality [Fig. 3(c)]. The same is evident in the ex-
periments: we see in Fig. 3(h) that low drug doses corre-
spond to long response times and high entropies, whereas
high drug doses correspond to short response times and
low entropies, resulting in an increase of response time
τr with entropy S. Calculating the entropy in Fig. 3(h)
requires a conversion between intensity I and molecule
number n, and we have checked that the results in Fig.
3(h) are qualitatively unchanged for different choices of
this conversion factor over several orders of magnitude.
The agreement between Figs. 3(g) and 3(h) offers further
evidence that the T cells experience critical slowing down,
with the data analysis completely independent from our
theory.
C. Dynamic driving and Kibble-Zurek collapse
While some environmental changes are sudden, many
changes in a biological context are gradual [Fig. 1(b),
5right]. When a gradual change drives a system through
its critical point, critical slowing down delays the sys-
tem’s response such that no matter how gradual the
change, the response lags behind the driving. Although
in a biological setting the driving protocol could take
many forms, terms beyond the leading-order linear term
do not change the critical dynamics [29]. This is a ma-
jor theoretical advantage because it allows us to special-
ize to linear driving without loss of biological realism.
Specifically, we focus on linear driving across the crit-
ical point with driving time τd, setting either θ(t) =
θi− (θf − θi)t/τd and h = 0, or h(t) = hi− (hf − hi)t/τd
and θ = 0, where i and f denote the initial and final
parameter values, respectively.
In a traditional equilibrium setting, the dynamics of
lagging trajectories are described in terms of the critical
exponents by the Kibble-Zurek mechanism [11, 12]. The
idea of the Kibble-Zurek mechanism is that far from the
critical point, the change in the system’s correlation time
due to the driving, over a correlation time, is small com-
pared to the correlation time itself, (dτc/dt)τc  τc, and
therefore the system responds adiabatically. However, as
the system is driven closer to the critical point, these two
quantities are on the same order, or dτc/dt ∼ 1, and the
system begins to lag. Applying this condition to Eqs. 7
and 8, and using the above expressions for θ(t) and h(t),
one obtains
θ ∼ τ−1/(νz+1)d , (13)
h ∼ τ−βδ/(νz+βδ)d , (14)
respectively. Because m ∼ (−θ)β or m ∼ h1/δ near criti-
cality in the mean-field Ising class, we have
m ∼ τ−β/(νz+1)d , (15)
m ∼ τ−β/(νz+βδ)d , (16)
respectively. Therefore, if the system is driven at dif-
ferent timescales τd, the Kibble-Zurek mechanism pre-
dicts that plots of the rescaled variables mτ
β/(νz+1)
d vs.
θτ
1/(νz+1)
d or mτ
β/(νz+βδ)
d vs. hτ
βδ/(νz+βδ)
d will collapse
onto universal curves.
When testing these predictions using simulations of a
spatially extended physical system, the finite size of the
system causes a truncation of the autocorrelation time.
This truncation is usually accounted for using a finite-
size correction [29]. In our system, a similar truncation of
the autocorrelation time is caused by the finite number of
molecules. Specifically, the inset of Fig. 2(b) shows that
at criticality we have τc ∼ n1/2c for large nc, where nc sets
the typical number of molecules in the system. Therefore,
we interpret nc as a “system size,” and we correct for
finite-size effects in the following way. Combining the
relation τc ∼ n1/2c with Eqs. 7 and 8, and Eqs. 13 and 14,
we obtain
nc ∼ τ2νz/(νz+1)d , (17)
nc ∼ τ2νz/(νz+βδ)d , (18)
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FIG. 4: Dynamic driving and Kibble-Zurek collapse. (a) As
reduced temperature θ is driven over time τd in Schlo¨gl model,
order parameter m lags behind due to critical slowing down.
Decreasing θ causes supercooling (left curves), while increas-
ing θ causes superheating (right curves), resulting in hystere-
sis. (b) Same, for driving h. (c, d) Rescaled curves collapse
as predicted. Each point is computed via Eq. 4 from the
mode n∗ in b, or the modes n
(1)
∗ < nc and n
(2)
∗ > nc in a, of
105 simulation trajectories. For finite-size correction we use
nc = 10τd in a and nc = 22τ
4/5
d in b. Time is in units of
1/k−1 .
for the driving of θ or h, respectively. We choose nc
arbitrarily for a particular driving time τd, and when we
choose a new τd, we scale nc appropriately according to
Eqs. 17 and 18.
This procedure allows us to test the predictions of the
Kibble-Zurek mechanism using simulations of the Schlo¨gl
model. The results are shown in Fig. 4. We see in Fig.
4(a) that as θ is driven from a positive to a negative
value, the bifurcation response is lagging, occurring at a
value less than the critical value θ = 0 (supercooling).
Conversely, when θ is driven from a negative to a posi-
tive value, the convergence occurs at a value greater than
θ = 0 (superheating). In both directions, the lag is larger
when the driving is faster, corresponding to smaller val-
ues of τd (from yellow to dark brown). We see in Fig.
4(b) that similar effects occur for the driving of h. Yet,
we see in Figs. 4(c) and (d) that the rescaled variables
collapse onto single, direction-dependent curves within
large regions near criticality. Note that the direction de-
pendence (i.e., hysteresis) is preserved as part of these
universal curves, but the lags vanish in the collapse. This
result demonstrates that our nonequilibrium birth-death
model exhibits the Kibble-Zurek collapse predicted for
critical systems. Together with our previous findings,
this result suggests that such a collapse should emerge in
biological experiments where environmental parameters
(e.g., drug dose) are dynamically controlled in a gradual
manner. More broadly, by phenomenologically collapsing
6such experimental curves, it should be possible to deduce
the critical exponents of such biological systems without
fine-tuning them to criticality, but instead by gradual
parameter sweeps.
III. DISCUSSION
We have investigated critical slowing down in a min-
imal stochastic model of biochemical feedback. By ex-
ploiting a mapping to Ising-like thermodynamic vari-
ables, we have made quantitative predictions for the re-
sponse of a system with feedback to both sudden and
gradual environmental changes. In response to a sud-
den change (a quench), we have shown that the system
will respond more slowly if the quench takes it closer to
its critical point, in qualitative agreement with multiple-
time-point flow cytometry experiments in immune cells.
In response to more gradual driving, we have shown that
the lagging dynamics of the system proceed according to
the Kibble-Zurek mechanism for driven critical phenom-
ena. Together, our results elucidate the consequences of
critical slowing down for biochemical systems with feed-
back, and demonstrate those consequences on an example
system from immunology.
For the immune cells, critical slowing down may
present a tradeoff in terms of the speed vs. the preci-
sion of an immune response. Specifically, ppERK is im-
plicated in the decision of whether or not to mount the
immune response [27, 28], suggesting that ppERK dy-
namics near the bifurcation point are of key biological
importance. Yet, the bifurcation point is the point where
critical slowing down is most pronounced. In fact, the in-
set of Fig. 2(b) demonstrates that the system slows down
as the number of molecules in the system increases. On
the other hand, large molecule number is known to de-
crease intrinsic noise and thereby increase the precision
of a response [30]. This suggests that cells may face a
tradeoff in terms of speed vs. precision when responding
to changes that occur near criticality, as suggested for
other biological systems [31, 32].
Our work extends the Kibble-Zurek mechanism to
a nonequilibrium biological context. Traditionally, the
mechanism has been applied to physical systems from
cosmology [11] and from hard [12, 33] or soft [34] con-
densed matter. Here, we extend the mechanism to the
context of biochemical networks with feedback, where the
system already exists in a nonequilibrium steady state,
and the external protocol takes the system further out
of equilibrium into a driven state. It will be interesting
to see to what other nonequilibrium contexts the Kibble-
Zurek mechanism can be successfully applied [35].
The theory we present here assumes only intrinsic
birth-death reactions and neglects more complex mech-
anisms such as bursting [36, 37], parameter fluctuations
[38, 39], or cell-to-cell variability [40, 41] that may play an
important role in the immune cells. Nonetheless, similar
models that also focus only on intrinsic noise have suc-
cessfully described ppERK in T cells in the past [42, 43].
Moreover, we expect that intrinsic fluctuations should
play their largest role near the bifurcation point. Finally,
we expect that near the bifurcation point, the essential
behavior of the system should be captured by any model
that falls within the appropriate universality class.
In this and previous work [10] we have explored the dy-
namic and static scaling properties of single cells subject
to biochemical feedback. Natural extensions include gen-
eralizing the theory to cell populations or other systems
that are not well-mixed such as intracellular compart-
ments. This would allow one to investigate the spatial
consequences of proximity to a bifurcation point, such as
long-range correlations in molecule numbers and the as-
sociated implications for sensing, information transmis-
sion, patterning, or other biological functions.
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Appendix A: Autocorrelation time
We calculate the autocorrelation time τc (Eq. 9) for
the Schlo¨gl model in steady state using one of two meth-
ods, the first more efficient for small molecule numbers,
and the second more efficient for large molecule numbers.
The first method is to calculate τc numerically from the
master equation for pn by eigenfunction expansion. The
master equation follows from the reactions in Eq. 5 [10]
and can be written in vector notation as
~˙p = L~p. (A1)
where L is a tridiagonal matrix containing the birth and
death propensities for X. The eigenvectors of L satisfy
L~vj = λj~vj , (A2)
~ujL = λj~uj , (A3)
where the eigenvalues obey λj ≤ 0 with only λ0 vanishing
for the steady state, and ~vTj 6= ~uj because L is not Her-
mitian [45]. Because Eq. A1 is linear in ~p, the solution
is
pn(t) =
∑
jn′
ujn′pn′(0)e
λjtvnj (A4)
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FIG. 5: Autocorrelation time computed (a) numerically using
eigenfunction expansion or (b) by simulation using method of
batch means. For sufficient cutoff N or trajectory duration
T , respectively, both methods converge to same value (dashed
line). Parameters: θ = h = 0 and nc = 100. Time is in units
of 1/k−1 . In (b), τb = 1000, and error bars are standard error
from 50 trajectories.
for initial condition pn(0). Calling n(0) ≡ m and n(t) ≡
n, we write the autocorrelation function (see Eq. 9) as
κ(t) = −n¯2+
∑
mn
pmnmn = −n¯2+
∑
mn
pn|mpmmn, (A5)
where pm = vm0 is the steady-state distribution, and
pn|m is the dynamic solution at time t assuming the sys-
tem starts with m molecules. That is, pn|m is given by
Eq. A4 with initial condition pn(0) = δnm. Eq. A5 be-
comes
κ(t) = −n¯2 +
∑
mn
mnvm0
∑
j
ujme
λjtvnj (A6)
=
∑
mn
mnvm0
∞∑
j=1
ujme
λjtvnj , (A7)
where the second step uses orthonormality,
∑
j vnjujn′ =
δnn′ , and probability conservation, u0n = 1, to recognize
that the j = 0 term evaluates to n¯2. Inserting Eq. A7 into
Eq. 9 and performing the integral (recalling that λj < 0
for j > 0), we obtain
τc =
1
σ2
∑
mn
mnvm0
∞∑
j=1
ujm
(
1
−λj
)
vnj . (A8)
In matrix notation,
τc = σ
−2~nVFU~w, (A9)
where ~n is a row vector, ~w = mvm0 is a column vector,
and neither the eigenvector matrices V and U nor the
diagonal matrix Fjj′ = −δjj′/λj contain the j = 0 term.
Numerically, we compute τc via Eq. A9 using a cutoff
N > nc for the vectors and matrices.
The second method is to calculate τc from stochastic
simulations [23] and the method of batch means [24]. The
idea is to divide a simulation trajectory of length T into
batches of length τb. In the limit T  τb  τc, the
correlation time can be estimated by [24]
τc =
τbσ
2
b
2σ2
, (A10)
where σ2b is the variance of the means of the batches.
In Fig. 5 we verify that the two methods converge to
the same limit for sufficiently large N or T , respectively.
We find that the first method is more efficient until nc ∼
1000, when numerically computing the eigenvectors for
large N > nc becomes intractable.
Appendix B: Experimental methods
The data in Fig. 6 [of which the smallest and largest
doses are reproduced in Fig. 3(d)] were acquired at the
same time and in a similar way as the data published
in [27] and summarized in [10]. The difference is that,
instead of only recording the data after steady state was
reached, the time series was sampled by applying a chem-
ical fixative to stop chemical reactions and preserve all
biomolecular states. Specifically, we administered ice
cold formaldehyde in PBS to each experimental well of a
96 well-v-bottom plate such that the final working dilu-
tion is 2%, and then transferred the cell-fixative solution
to a new 96 well-v-bottom plate on ice. Cells were kept
on ice for 10 minutes and then precipitated by centrifuga-
tion, resuspended in ice-cold 90% methanol, and placed
in a −20 oC freezer until measurements were taken.
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